Samsung Biologics’ upcoming $1.5-billion production plant will be ready for operation by April 2025, five months earlier than previously expected, according to the pharmaceutical...
Samsung Biologics inked a $112.5 million contract manufacturing organization (CMO) letter of intent with an unnamed U.S. biopharmaceutical firm, the Korean company said in...
Samsung Electronics will join Intel, Nvidia and Google in developing an open-source semiconductor software system in an effort to reduce reliance on British chip...
Samsung SDI is pushing hard for environmental, social and corporate governance (ESG) management, with the goal of fully running its global production facilities only...
SK networks’ investment subsidiary will work with Bow Capital, a U.S. venture fund, in early-stage venture investments, the parent company said Wednesday.
Hico Capital, a...
Three HYBE employees have been referred to the prosecution for insider trading, financial authorities said Wednesday.
The Financial Supervisory Service allege that they sold their...
Samsung Biologics will be heavily promoting its capabilities in contract development and manufacturing organization (CDMO) at the BIO International Convention 2023 (BIO USA) in...
